1. MiR-325 Promotes Oxaliplatin-Induced Cytotoxicity Against Colorectal Cancer Through the HSPA12B/PI3K/AKT/Bcl-2 Pathway
   Li Zhang et al, 2020, Dig Dis Sci CrossRef
2. Gankyrin as Potential Biomarker for Colorectal Cancer With Occult Liver Metastases
   Chengxing Wang et al, 2021, Front. Oncol. CrossRef
3. CRISPR-based knockout screening identifies the loss of MIEF2 to enhance oxaliplatin resistance in colorectal cancer through inhibiting the mitochondrial apoptosis pathway
   Chaozheng Xie et al, 2022, Front. Oncol. CrossRef
4. Dihydroartemisinin, an artemisinin derivative, reverses oxaliplatin resistance in human colorectal cancer cells by regulating the SIRT3/PI3K/AKT signalling pathway.
   Xiaodong Shen et al, 2024 CrossRef